Skip to main content
Premium Trial:

Request an Annual Quote

Blue Heron Biotechnology Wins SBIR Grant to Develop Protein Display Bead Technology

NEW YORK, Sept. 16 (GenomeWeb News) - Blue Heron Biotechnology has received a Phase I SBIR grant from the National Human Genome Research Institute to develop a protein display bead technology, the company said yesterday.

 

The amount of the grant was not immediately available from the company, but NIH databases list a six-month, $133,183 grant for fiscal year 2005, entitled "Protein-Display Beads," that started Sept. 1.

 

The beads will be used to study protein function in high throughput. Each bead in a large pool will carry a unique DNA sequence and the protein encoded by that sequence.

 

According to the NIH database, Blue Heron plans to commercialize the technology for characterizing and optimizing proteins of medical and industrial value. The company plans to provide it as a service for existing customers and use it for internal research projects.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.